Max Wicha
Impact in
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Cancer, Hypoxia, and Metabolism
- Oncology top 10%
- Cancer Cells and Metastasis
- Metal complexes synthesis and properties
- Drug Transport and Resistance Mechanisms
Papers in ⓘ
- Oncology 4
- Cancer Treatment and Pharmacology 2
- Cancer-related Molecular Pathways 1
-
- Cancer Genomics and Diagnostics 3
- Breast Cancer Treatment Studies 2
- Co-authors
- Michael Brooks (1 shared paper)Ming Luo (1 shared paper)Sofía D. Merajver (2 shared papers)Myla Strawderman (2 shared papers)Thierry Jahan (1 shared paper)Michael T. Tseng (1 shared paper)Gerald L. LeCarpentier (1 shared paper)Bruce G. Redman (1 shared paper)
- Journals
- Cancer Research (3 papers)Cancer (1 paper)Journal of Clinical Oncology (1 paper)Current Pharmaceutical Design (1 paper)Breast Cancer Research and Treatment (1 paper)
- Partner nations
- United StatesNetherlandsUnited Kingdom
In The Last Decade
Max Wicha
8 papers receiving 565 citations
Peers
Comparison fields: 5 of 77
- Cancer Research 192
- Oncology 301
- Nutrition and Dietetics 119
- Immunology and Allergy 38
- Pathology and Forensic Medicine 58
Countries citing papers authored by Max Wicha
This map shows the geographic impact of Max Wicha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Wicha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Wicha more than expected).
Fields of papers citing papers by Max Wicha
This network shows the impact of papers produced by Max Wicha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Wicha. The network helps show where Max Wicha may publish in the future.
Co-authors
The 25 scholars most cited alongside Max Wicha, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study. | 2000 | 273 |
| 2 | 2015 | 168 | |
| 3 | 1997 | 84 | |
| 4 | 2011 | 51 | |
| 5 | 2005 | 3 | |
| 6 | 2007 | 1 | |
| 7 | 2013 | 1 | |
| 8 | 2015 | 1 | |
| 9 | 2010 | 0 |
About Max Wicha
Max Wicha is a scholar working on Oncology, Cancer Research, Molecular Biology, Organic Chemistry and Surgery, having authored 9 papers that have together received 582 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (3 papers), Cancer Treatment and Pharmacology (2 papers), Breast Cancer Treatment Studies (2 papers), Lymphoma Diagnosis and Treatment (1 paper), Trace Elements in Health (1 paper), Cancer-related Molecular Pathways (1 paper), Click Chemistry and Applications (1 paper) and Pain Management and Opioid Use (1 paper). The work is most often cited by research in Cancer Research (192 citations), Oncology (301 citations), Nutrition and Dietetics (119 citations), Immunology and Allergy (38 citations) and Pathology and Forensic Medicine (58 citations). Max Wicha has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Michael Brooks, Ming Luo, Sofía D. Merajver, Myla Strawderman, Thierry Jahan, Michael T. Tseng, Gerald L. LeCarpentier, Bruce G. Redman, Robert D. Dick and George J. Brewer. Their work appears in journals such as Cancer Research, Cancer, Journal of Clinical Oncology, Current Pharmaceutical Design and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.